Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: April 07, 2022
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer.
Journal: The oncologist
Published: July 12, 2021
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.
Journal: Cancer discovery
Published: March 11, 2021
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 20, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026